Tuesday, 10 December 2024 Reading time : 2 minutes

French equities have given investors little to cheer about this year. Looking at the major European stock markets, only the Paris Bourse has lost ground since January: the French Blue Chip Index, which includes the forty largest French companies, is down 0.3% (as of 6 December, total return). The EuroStoxx 50 has gained around 9% over the same period.

Among the biggest losers are two stock market heavyweights, cosmetics giant L'Oréal (-23.5%) and luxury goods company LVMH (-13.9%). They belong to the top three French companies in terms of market capitalisation. The year was better for the third corporate in the club: Hermès, LVMH's competitor, gains almost 18%. 

With a market capitalisation of more than EUR 100 billion, Schneider Electric is also one of the most valuable French companies. The industrial group's shares are in demand in 2024 and are currently trading more than 38% higher than at the beginning of the year. 

Sanofi's performance has been less spectacular, with a gain of 2.6%, but is still above average compared with the overall index. The pharmaceutical company also has a market capitalisation of more than EUR 100 billion.

Together, the five companies account for around 34% of the Cac 40, according to Euronext data. For investors who want to take advantage of the investment opportunities offered by the French stock exchange, the Barrier Reverse Convertible on L'Oréal, LVMH, Hermès, Schneider Electric and Sanofi combines the stocks of five of the largest companies on the Paris stock exchange. The product is equipped with a quanto feature, so there is no currency risk for CHF investors.

Barrier Reverse Convertible on French Equities
11.00% p.a. BRC on L'Oreal, LVMH, Hermes, Schneider Electric and Sanofi
Barrier: 68%
Valor: 140 249 851

Indicative terms

Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements. The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document. If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.
© 2024 Zürcher Kantonalbank. All rights reserved.